Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Neoplasms of the CNS

  Free Subscription


07.09.2020

1 BMC Cancer
1 Br J Neurosurg
1 Childs Nerv Syst
1 Clin Neuropathol
1 Int J Cancer
1 J Neurol
2 J Neurooncol
1 J Neurosurg
2 J Nucl Med
1 Nat Rev Neurol
5 Neuro Oncol
1 Neuroradiology
4 Neurosurgery
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. WANG J, Liu Z, Pang Q, Zhang T, et al
    Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
    BMC Cancer. 2020;20:837.
    PubMed         Abstract available


    Br J Neurosurg

  2. TURK O, Ozdemir NG, Atci IB, Yilmaz H, et al
    A rare case of cervical metastatis of glioblastoma after cranial tumor resection: case report and review of literature.
    Br J Neurosurg. 2020 Sep 1:1-7. doi: 10.1080/02688697.2020.1814994.
    PubMed         Abstract available


    Childs Nerv Syst

  3. KANEVA K, Wadhwani N, DiPatri AJ Jr, Palasis S, et al
    Benign skull and subdural lesions in patients with prior medulloblastoma therapy.
    Childs Nerv Syst. 2020 Sep 2. pii: 10.1007/s00381-020-04874.
    PubMed         Abstract available


    Clin Neuropathol

  4. SALEH C, Jaszczuk P, Hund-Georgiadis M, Frank S, et al
    Differentiation of rare brain tumors through unsupervised machine learning: Clinical significance of in-depth methylation and copy number profiling illustrated through an unusual case of IDH wildtype glioblastoma.
    Clin Neuropathol. 2020 Sep 1. pii: 187233. doi: 10.5414/NP301305.
    PubMed         Abstract available


    Int J Cancer

  5. ZHANG Y, Xie A, Quan F, Hou X, et al
    Identifying bifurcated paths with differential function impact in glioblastomas evolution.
    Int J Cancer. 2020 Sep 1. doi: 10.1002/ijc.33276.
    PubMed         Abstract available


    J Neurol

  6. DECAVELE M, Gatulle N, Weiss N, Rivals I, et al
    One-year survival of patients with high-grade glioma discharged alive from the intensive care unit.
    J Neurol. 2020 Aug 29. pii: 10.1007/s00415-020-10191.
    PubMed         Abstract available


    J Neurooncol

  7. TSENG CL, Stewart J, Whitfield G, Verhoeff JJC, et al
    Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.
    J Neurooncol. 2020 Aug 29. pii: 10.1007/s11060-020-03605.
    PubMed         Abstract available

  8. BROWN DA, Goyal A, Kerezoudis P, Alvi MA, et al
    Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
    J Neurooncol. 2020 Aug 28. pii: 10.1007/s11060-020-03604.
    PubMed         Abstract available


    J Neurosurg

  9. NAVARRIA P, Pessina F, Clerici E, Rossini Z, et al
    Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    J Neurosurg. 2020 Sep 4:1-14. doi: 10.3171/2020.5.JNS201116.
    PubMed         Abstract available


    J Nucl Med

  10. MIRIAN C, Duun-Henriksen AK, Maier AD, Pedersen MM, et al
    Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249607. doi: 10.2967/jnumed.120.249607.
    PubMed         Abstract available

  11. FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
    Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.
    PubMed        


    Nat Rev Neurol

  12. SOFFIETTI R, Ahluwalia M, Lin N, Ruda R, et al
    Management of brain metastases according to molecular subtypes.
    Nat Rev Neurol. 2020 Sep 1. pii: 10.1038/s41582-020-0391.
    PubMed         Abstract available


    Neuro Oncol

  13. LOBBOUS M, Nabors LB
    A troublesome burden, the amplification of EGFR in glioblastoma!
    Neuro Oncol. 2020;22:594-595.
    PubMed        

  14. BRANDSMA D, van den Bent MJB
    Quantification of leptomeningeal metastases from solid tumors remains a challenging issue.
    Neuro Oncol. 2020;22:592-593.
    PubMed        

  15. SANTANA-CODINA N, Gonzalez J, Sierra A
    Reply to Letter to the Editor.
    Neuro Oncol. 2020;22:734-735.
    PubMed        

  16. KOTECHA R, Hall MD
    Impact of Radiotherapy Dosimetric Parameters on Neurocognitive Function in Brain Tumor Patients.
    Neuro Oncol. 2020 Sep 2. pii: 5900405. doi: 10.1093.
    PubMed        

  17. BALANA C, Carrato C, Vaz MA
    Reply to: 'Extended adjuvant temozolomide in newly diagnosed glioblastoma: is more less?'
    Neuro Oncol. 2020 Sep 4. pii: 5901531. doi: 10.1093.
    PubMed        


    Neuroradiology

  18. PARK YW, Ahn SS, Kim EH, Kang SG, et al
    Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.
    Neuroradiology. 2020 Sep 2. pii: 10.1007/s00234-020-02542.
    PubMed         Abstract available


    Neurosurgery

  19. ZAAZOUE MA, Manley PE, Kapur K, Ullrich NJ, et al
    Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children.
    Neurosurgery. 2019 Apr 15. pii: 5465891. doi: 10.1093.
    PubMed         Abstract available

  20. CASTANO-LEON AM, Paredes I, Munarriz PM, Jimenez-Roldan L, et al
    Endoscopic Transnasal Trans-Sphenoidal Approach for Pituitary Adenomas: A Comparison to the Microscopic Approach Cohort by Propensity Score Analysis.
    Neurosurgery. 2019 Jun 7. pii: 5512289. doi: 10.1093.
    PubMed         Abstract available

  21. BAJAJ J, Yadav YR
    Letter: 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
    Neurosurgery. 2020 Aug 28. pii: 5898779. doi: 10.1093.
    PubMed        

  22. CHEN WC, Vasudevan HN, Choudhury A, Pekmezci M, et al
    A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection.
    Neurosurgery. 2020 Aug 29. pii: 5898934. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  23. KOPER-LENKIEWICZ OM, Kaminska J, Reszec J, Dymicka-Piekarska V, et al
    Elevated plasma 20S proteasome chymotrypsin-like activity is correlated with IL-8 levels and associated with an increased risk of death in glial brain tumor patients.
    PLoS One. 2020;15:e0238406.
    PubMed         Abstract available

  24. LIM SJ, Yeo I, Park CW, Lee H, et al
    Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
    PLoS One. 2020;15:e0238368.
    PubMed         Abstract available

  25. MINEA RO, Duc TC, Swenson SD, Cho HY, et al
    Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    PLoS One. 2020;15:e0238238.
    PubMed         Abstract available

  26. WILHELMY F, Hantsche A, Wende T, Kasper J, et al
    Perioperative anticoagulation in patients with intracranial meningioma: No increased risk of intracranial hemorrhage?
    PLoS One. 2020;15:e0238387.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: